Literature DB >> 15221906

Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes.

R W Roest1, W F Carman, J Maertzdorf, A Scoular, J Harvey, M Kant, W I Van Der Meijden, Georges M G M Verjans, A D M E Osterhaus.   

Abstract

Clinical recurrences of Herpes simplex virus type 1 (HSV-1)-associated genital herpes are thought to be caused by reactivation of latent endogenous HSV-1. However, the possibility of reinfection with exogenous HSV-1 cannot be excluded. This study aimed to determine the incidence of genital HSV-1 superinfection in patients by investigating the genotype of sequential HSV-1 isolates obtained from the same anatomical site of patients with clinical recurrences of genital HSV-1 recurrent genital herpes. Sequential genital HSV-1 isolates were genotyped by PCR amplification of the hypervariable regions located within the HSV-1 genes US1 and US12. Whereas the sequential HSV-1 isolates in 11 of the 13 patients studied had the same genotypes, the sequential isolates of 2 patients showed a different genotype. The data suggest that HSV-1-induced recurrent genital herpes can be associated with genital reinfection with an exogenous HSV-1 strain. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221906     DOI: 10.1002/jmv.20132

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Preventing sexually transmitted infections: back to basics.

Authors:  Anne Rompalo
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Should sexually transmitted disease clinics routinely offer serologic testing for genital herpes?

Authors:  Michael F Rein
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

3.  Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains.

Authors:  Emily Toth Martin; David M Koelle; Benjamin Byrd; Meei-Li Huang; Jeffrey Vieira; Lawrence Corey; Anna Wald
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 4.  HSV-2: in pursuit of a vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

5.  Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains.

Authors:  C Deback; D Boutolleau; C Depienne; C E Luyt; P Bonnafous; A Gautheret-Dejean; I Garrigue; H Agut
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

6.  Molecular method development and establishment of a database for clinical and epidemiological herpes simplex virus 1 strain comparisons.

Authors:  Amy B Dean; Kirsten St George
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

7.  Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

Authors:  Monique van Velzen; Werner J D Ouwendijk; Stacy Selke; Suzan D Pas; Freek B van Loenen; Albert D M E Osterhaus; Anna Wald; Georges M G M Verjans
Journal:  J Med Virol       Date:  2013-06-18       Impact factor: 2.327

8.  Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.

Authors:  Andrea R McWhorter; Lee M Smith; Laura L Masters; Baca Chan; Geoffrey R Shellam; Alec J Redwood
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

Review 9.  Identifying HIV-1 dual infections.

Authors:  Antoinette C van der Kuyl; Marion Cornelissen
Journal:  Retrovirology       Date:  2007-09-24       Impact factor: 4.602

10.  Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigation.

Authors:  Ilka Engelmann; Jens Gottlieb; Astrid Meier; Dorit Sohr; Arjang Ruhparwar; Cornelia Henke-Gendo; Petra Gastmeier; Tobias Welte; Thomas Friedrich Schulz; Frauke Mattner
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.